Select license type

Please Select Linenece Type

Key Benefits

  • Consult directly with our domain leaders and get expert advice regarding the upcoming market.
  • Get the latest market insights and forecasts backed up by powerful research and statistical analysis
  • Customize the report as per your requirements and area of focus to avail great benefits for your business.
Market Research Report

African Pharmaceutical Market - Industry Analysis & Forecast 2016-2024

Published On : 2018-01-30 Report Page : 240 Category: Healthcare

Africa Pharmaceutical Market

Market Overview

Half of Africans do not have access to essential drugs. With the provision of the right drugs to treat respiratory infections, diarrheal diseases and malaria, around 10 million lives would have been saved in 2015. Every 30 seconds one African child is killed due to malaria. The 10 largest pharmacy retail chains in Nigeria, Kenya and Ghana manage 186 outlets for a population of almost a quarter of a billion people.

Goldstein Research analyst forecast the Africa pharmaceuticals market size is set to reach USD 160.7 billion by 2024, at a CAGR of 20.4% over the forecast years.

Covered In This Africa Pharmaceutical Market Report                

The report covers the present ground scenario and the future growth prospects of Africa Pharmaceuticals Market for 2016-2024 and statistics of Branded and Generic Drugs along with the details of ongoing projects in pharma sector in Africa. We calculated the market size and revenue share on the basis of revenue generated from major players across the globe.

Africa Pharmaceutical Market Segmentation

By Type

  • Active Pharmaceutical Ingredients (APIs)
  • Branded
  • Generics
  • Contract Research and Manufacturing Services
  • Formulations (CRAMS)
  • Chronic
  • Cardiovascular
  • Anti-Diabetes
  • Gastro Intestinal
  • Neurological
  • Acute
  • Anti-infectives
  • Respiratory
  • Pain
  • Gynecology
  • Biosimilars

By Geography

  • Nigeria {Market Share (%), Market Size (USD Billion), Sales (Million Unit)}
  • Egypt {Market Share (%), Market Size (USD Billion), Sales (Million Unit)}
  • South Africa {Market Share (%), Market Size (USD Billion), Sales (Million Unit)}
  • Algeria {Market Share (%), Market Size (USD Billion), Sales (Million Unit)}
  • Morocco {Market Share (%), Market Size (USD Billion), Sales (Million Unit)}
  • Ethiopia {Market Share (%), Market Size (USD Billion), Sales (Million Unit)}
  • Kenya {Market Share (%), Market Size (USD Billion), Sales (Million Unit)}
  • Rest of the Africa {Market Share (%), Market Size (USD Billion), Sales (Million Unit)}

On the basis of type, the anti-infective therapeutic segment will remain the primary market in the region due to high AIDS and malaria burden contributing nearly 45% of total pharmaceutics market.

Africa Pharmaceuticals Market Outlook 2016-2024, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the Africa pharmaceuticals market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Africa Pharmaceutical market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

Our Africa Pharmaceutical market report comprises of the following companies as the key players in the market: Sun Pharma, Cipla, Candila. Glenmark, Glaxo Smithkline, Abbott Africa, Biocon, Jubilant life, Sanofi Africa, Elys, Pfizer, Cosmos, Bayer, Emzor, Fidson, Dawa, Regal, Lab and Allied, Roche, AstraZeneca, Merck.

According to our market study on the basis of extensive primary and secondary research:  “One trend is consolidation of pharma companies. For instance, Clicks, a South African pharmacy chain, now owns the largest pharma wholesaler in South Africa and Botswana. Again in South Africa, Shoprite has bought a local drug wholesaler to help its pharmacies expand into rural areas and offer customer deliveries.”

According to the report, major driving factor for Africa pharmaceutical market is the expansion of healthcare capacity which according to the World Bank Africa acquired 70,000 new hospital beds, 16,000 doctors, and 60,000 nurses, adding up to a total of 1,050,000 beds, 498,370 doctors, and 1,250,000 nurses between 2005 and 2012.

Further, the report states that the major challenge is the establishment of reliable supply and distribution mechanism as regulations are still evolving, transportation and logistics infrastructure remains patchy, therefore lead times can be long.

Based on geographies, due to healthcare challenges in Ghana, Senegal, Tanzania, Kenya, Benin and Malawi among others in Africa, hold the opportunities in future. South Africa has the largest market in pharmaceuticals among other African countries. Also, healthcare system in Uganda is in a mess due to lack of government incentives while Zambia is the ideal country when it comes to how a democracy should work.  

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this Africa Pharmaceutical Market report

  • What is the total market size by 2024 and what would be the expected growth rate of Africa Pharmaceutical Industry?
  • What is the revenue of Africa Pharmaceutical Market in 2015-16 and what would be the expected demand over the forecast period?
  • What are the key market trends?
  • What are the factors which are driving this market?
  • What are the major barriers to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities for the existing and entry level players?
  • What are the recent developments and business strategy of the key players?

We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.


A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements


African Pharmaceutical Market - Industry Analysis & Forecast 2016-2024

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

OR Call Us:+1-646-568-7747

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements